Be part of the future!

MINT’s associated companies, Mundipharma Research Limited in Cambridge and Mundipharma Research GmbH in Germany, are young, dynamic companies dedicated to the research and development of highly effective and innovative medications.

The main focus is applied research and development. This means that Mundipharma Research converts scientific findings into practical and patient-oriented applications by working on pre-clinical research, pharmaceutical development, clinical development, drug safety, regulatory affairs, and scientific support.

Mundipharma Research develops new medications and optimises the effectiveness of known substances that will offer therapeutic progress for patients.  All activities are based upon giving patients a greater quality of life, fulfilling the highest ethical demands whilst meeting scientific curiosity with creativity.

An internal innovation process and ongoing dialogue with partners has taught us to recognise the true needs of doctors and patients. That is how, for example, Targin® was developed in-house for the treatment of severe pain. Mundipharma Research concentrates on three therapeutic areas: pain, oncology and respiratory diseases.

The use of the appropriate project management techniques ensures a swift and effective achievement of objectives and provides the very best foundations for delivering excellent results. 

Our code of values, professional skills and knowledge, and our leadership style are pivotal to the distinctive character of Mundipharma Research.